Roflumilast and Forced expiratory volume decreased - a phase IV clinical study of FDA data
Forced expiratory volume decreased is reported only by a few people who take Roflumilast.
The phase IV clinical study analyzes which people take Roflumilast and have Forced expiratory volume decreased. It is created by eHealthMe based on reports of 1,880 people who have side effects while taking Roflumilast from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,880 people reported to have side effects when taking Roflumilast.
Among them, 4 people (0.21%) have Forced expiratory volume decreased.
What is Roflumilast?
Roflumilast has active ingredients of roflumilast. eHealthMe is studying from 1,884 Roflumilast users for its effectiveness, alternative drugs and more.
What is Forced expiratory volume decreased?
Forced expiratory volume decreased (decreased lung expired air volume) is found to be associated with 461 drugs and 236 conditions by eHealthMe.
Number of Roflumilast and Forced expiratory volume decreased reports submitted per year:
Gender of people who have Forced expiratory volume decreased when taking Roflumilast *:
- female: 25 %
- male: 75 %
Age of people who have Forced expiratory volume decreased when taking Roflumilast *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 25 %
- 60+: 75 %
Common drugs people take besides Roflumilast *:
- Budesonide: 2 people, 50.00%
- Xolair: 1 person, 25.00%
- Ventolin: 1 person, 25.00%
- Spiriva: 1 person, 25.00%
- Singulair: 1 person, 25.00%
- Prednisone: 1 person, 25.00%
- Moxifloxacin: 1 person, 25.00%
- Atrovent: 1 person, 25.00%
- Advair Hfa: 1 person, 25.00%
- Acetylcysteine: 1 person, 25.00%
Common side effects people have besides Forced expiratory volume decreased *:
- Breathing Difficulty: 4 people, 100.00%
- Wheezing (a high-pitched whistling sound made while you breath): 3 people, 75.00%
- Vital Capacity Decreased: 2 people, 50.00%
- Lung Hyperinflation (inspiration of more than normal): 2 people, 50.00%
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 25.00%
- High Blood Pressure: 1 person, 25.00%
- Heart Rate Increased: 1 person, 25.00%
- Heart Rate Decreased: 1 person, 25.00%
- Foot Fracture: 1 person, 25.00%
- Fever: 1 person, 25.00%
Common conditions people have *:
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 25.00%
- Breathing Difficulty: 1 person, 25.00%
- Asthma: 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Roflumilast and have Forced expiratory volume decreased?Check whether Forced expiratory volume decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Forced expiratory volume decreased and when was it recovered:
Expand to all the drugs that have ingredients of roflumilast:
Alternative drugs to, pros and cons of Roflumilast:
- Roflumilast (1,884 reports)
Common Roflumilast side effects:
Browse all side effects of Roflumilast:a b c d e f g h i j k l m n o p q r s t u v w x y z
Forced expiratory volume decreased treatments and more:
- Forced expiratory volume decreased (4,343 reports)
COVID vaccines that are related to Forced expiratory volume decreased:
- Forced expiratory volume decreased in Moderna COVID Vaccine
- Forced expiratory volume decreased in Pfizer BioNTech Covid Vaccine
- Forced expiratory volume decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Forced expiratory volume decreased:
All the drugs that are associated with Forced expiratory volume decreased:
- Forced expiratory volume decreased (461 drugs)
Common conditions associated with Forced expiratory volume decreased:
- Acid reflux: 214 reports
- Asthma: 3,322 reports
- Breathing difficulty: 203 reports
- Chronic asthma: 2,935 reports
- Cystic fibrosis: 366 reports
- Difficulty in breathing: 222 reports
- Exercise-induced asthma: 3,321 reports
- Gastroesophageal reflux disease: 259 reports
- High blood pressure: 286 reports
- Hypersensitivity: 138 reports
All the conditions that are associated with Forced expiratory volume decreased:
- Forced expiratory volume decreased (236 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on roflumilast (the active ingredients of Roflumilast) and Roflumilast (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prednisolone and Vagifem drug interaction - 11 seconds ago
- Hair Loss in Nitrofurantoin, how severe and when it was recovered? - 13 seconds ago
- L-Lysine and Vfend drug interaction - 24 seconds ago
- Aristocort and Avandia drug interaction - 45 seconds ago
- Pantoprazole Sodium and Tooth Abscess - 51 seconds ago
- Sodium Bicarbonate and Xgeva drug interaction - 58 seconds ago
- Mirapex vs. Ativan - a minute ago
- Lanoxin and Pain - 2 minutes ago
- Remicade and Blood Testosterone Decreased - 2 minutes ago
- Dimenhydrinate and Gabapentin drug interaction - 2 minutes ago